FOUNDATION FIGHTING BLINDNESS RETINAL DEGENERATION FUND sold 42.1% of their position (4M shares) of OPUS GENETICS, INC. on the open market
Open‑market sale worth $8.60M — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 12/11/2025ACC: 0002042266-25-000003
→
DirectorOther
Since Oct 2024
-4M
Net shares
Net seller
$8.60M
Total sold
1
Open market trades
0B · 1S
1
Total transactions
4M disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−4M
Price / share
$2.15
Trade value
$8.60M
% of position
42.1%
12/9/2025
9.49M→5.49M
Total
Net shares
−4M
Net value
-$8.60M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 12/9/2025 | S · Sale | −4M | $2.15 | $8.60M | 42.1% | 9.49M | 5.49M |
| Total | −4M | -$8.60M | ||||||
Derivative Transactions0
No derivative transactions reported